DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain

Journal of Neurochemistry

Volumn 115, Issue 1, 2010, Pages 283-295

  Buira, Sandra P ^a   Dentesano, Guido ^a   Albasanz, José Luis ^b   Moreno, Jesús ^a   Martín, Mairena ^b   Ferrer, Isidre ^a,c,d   Barrachina, Marta ^a,d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

ADORA2A; DNA methylation; YY1; ZBP 89

Indexed keywords

ADENOSINE A2A RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR YY1; 5' UNTRANSLATED REGION; DNA BINDING PROTEIN; RNA; TRANSCRIPTION FACTOR; YY1 PROTEIN, HUMAN; ZNF148 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN; BRAIN REGION; CEREBELLUM; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PUTAMEN; WESTERN BLOTTING; 5' UNTRANSLATED REGION; BIOSYNTHESIS; BRAIN LEVEL; CELL LINE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5' UNTRANSLATED REGIONS; AGED; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL LINE; CEREBELLUM; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PUTAMEN; RECEPTOR, ADENOSINE A2A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION; YY1 TRANSCRIPTION FACTOR;

EID: 77956600971     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06928.x     Document Type: Article

References (65)

1. Affar el B., Gay F., Shi Y., Liu H., Huarte M., Wu S., Collins T., Li E. Shi Y. (2006) Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol. Cell. Biol. 26, 3565 3581.
2. Albasanz J. L., Rodríguez A., Ferrer I. Martín M. (2007) Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases. Eur. J. Neurosci. 26, 3501 3508.
3. Albasanz J. L., Perez S., Barrachina M., Ferrer I. Martín M. (2008) Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease. Brain Pathol. 18, 211 219.
4. Angulo E., Casadó V., Mallol J., Canela E. I., Viñals F., Ferrer I., Lluis C. Franco R. (2003) A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol. 13, 440 451.
5. Bai L. Merchant J. L. (2001) ZBP-89 promotes growth arrest through stabilization of p53. Mol. Cell. Biol. 21, 4670 4683.
6. Bai L. Merchant J. L. (2003) Transcription factor ZBP-89 is required for STAT1 constitutive expression. Nucleic Acids Res. 31, 7264 7270.
7. Bai L. Merchant J. L. (2007) ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. Biochem. Biophys. Res. Commun. 359, 817 821.
8. Bai L., Yoon S. O., King P. D. Merchant J. L. (2004) ZBP-89-induced apoptosis is p53-independent and requires JNK. Cell Death Differ. 11, 663 673.
9. Barrachina M. Ferrer I. (2009) DNA methylation of Alzheimer disease and tauopathy-related genes in post-mortem brain. J. Neuropathol. Exp. Neurol. 68, 880 891.
10. Boopathi E., Lenka N., Prabu S. K., Fang J. K., Wilkinson F., Atchison M., Giallongo A. Avadhani N. G. (2004) Regulation of murine cytochrome c oxidase Vb gene expression during myogenesis: YY1 and heterogeneous nuclear ribonucleoprotein D-like protein (JKTBP1) reciprocally regulate transcription activity by physical interaction with the BERF-1/ZBP-89 factor. J. Biol. Chem. 279, 35242 35254.
11. Buira S. P., Albasanz J. L., Dentesano G., Moreno J., Martín M., Ferrer I. Barrachina M. (2010) DNA methylation regulates adenosine A2A receptor cell surface expression levels. J. Neurochem. 112, 1273 1285.
12. Byun H. M., Siegmund K. D., Pan F., Weisenberger D. J., Kanel G., Laird P. W. Yang A. S. (2009) Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum. Mol. Genet. 18, 4808 4817.
13. Calon F., Dridi M., Hornykiewicz O., Bédard P. J., Rajput A. H. Di Paolo T. (2004) Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain 127, 1075 1084.
14. Canas P. M., Porciúncula L. O., Cunha G. M., Silva C. G., Machado N. J., Oliveira J. M., Oliveira C. R. Cunha R. A. (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. 29, 14741 14751.
15. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M. Werner T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933 2942.
16. Chen J. F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S. Schwarzschild M. A. (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192 9200.
17. Chiang M. C., Lee Y. C., Huang C. L. Chern Y. (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J. Biol. Chem. 280, 14331 14340.
18. Chupreta S., Brevig H., Bai L., Merchant J. L. Iñiguez-Lluhí J. A. (2007) Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89. J. Biol. Chem. 282, 36155 36166.
19. Cunha R. A. (2005) Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal. 1, 111 134.
20. Cunha G. M., Canas P. M., Melo C. S., Hockemeyer J., Müller C. E., Oliveira C. R. Cunha R. A. (2008) Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp. Neurol. 210, 776 781.
21. Dall'Igna O. P., Fett P., Gomes M. W., Souza D. O., Cunha R. A. Lara D. R. (2007) Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp. Neurol. 203, 241 245.
22. Ehrich M., Nelson M. R., Stanssens P., Zabeau M., Liloglou T., Xinarianos G., Cantor C. R., Field J. K. van den Boom D. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA 102, 15785 15790.
23. Fredholm B. B., IJzerman A. P., Jacobson K. A., Klotz K. N. Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527 552.
24. Gebhard C., Benner C., Ehrich M. et al. (2010) General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res. 70, 1398 1407.
25. Gordon S., Akopyan G., Garban H. Bonavida B. (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25, 1125 1142.
26. Hasegawa T., Xiao H. Isobe K. (1999) Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter. Biochem. Biophys. Res. Commun. 256, 249 254.
27. He Y. Casaccia-Bonnefil P. (2008) The Yin and Yang of YY1 in the nervous system. J. Neurochem. 106, 1493 1502.
28. Illingworth R. S. Bird A. P. (2009) CpG islands -"A rough guide". FEBS Let. 583, 1713 1720.
29. Jones P. A., Smith R. A. Stone T. W. (1998) Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res. 800, 328 335.
30. Keates A. C., Keates S., Kwon J. H., Arseneau K. O., Law D. J., Bai L., Merchant J. L., Wang T. C. Kelly C. P. (2001) ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells. J. Biol. Chem. 276, 43713 43722.
31. Ladd-Acosta C., Pevsner J., Sabunciyan S. et al. (2007) DNA methylation signatures within the human brain. Am. J. Hum. Genet. 81, 1304 1315.
32. Law G. L., Itoh H., Law D. J., Mize G. J., Merchant J. L. Morris D. R. (1998) Transcription factor ZBP-89 regulates the activity of the ornithine decarboxylase promoter. J. Biol. Chem. 273, 19955 19964.
33. Law D. J., Labut E. M. Merchant J. L. (2006) Intestinal overexpression of ZNF148 suppresses ApcMin/+ neoplasia. Mamm. Genome 17, 999 1004.
34. Le F., Townsend-Nicholson A., Baker E., Sutherland G. R. Schofield P. R. (1996) Characterization and chromosomal localization of the human A2a adenosine receptor gene: ADORA2A. Biochem. Biophys. Res. Commun. 223, 461 467.
35. MacCollin M., Peterfreund R., MacDonald M., Fink J. S. Gusella J. (1994) Mapping of a human A2a adenosine receptor (ADORA2A) to chromosome 22. Genomics 20, 332 333. (Pubitemid 24108424)
36. Malo M. S., Mozumder M., Zhang X. B., Biswas S., Chen A., Bai L. C., Merchant J. L. Hodin R. A. (2006) Intestinal alkaline phosphatase gene expression is activated by ZBP-89. Am. J. Physiol. Gastrointest. Liver Physiol. 290, 737 746.
37. Meng F., Xie G. X., Chalmers D., Morgan C., Watson Jr. S. J. Akil H. (1994) Cloning and expression of the A2a adenosine receptor from guinea pig brain. Neurochem. Res. 19, 613 621. (Pubitemid 24139256)
38. Merchant J. L., Iyer G. R., Taylor B. R., Kitchen J. R., Mortensen E. R., Wang Z., Flintoft R. J., Michel J. B. Bassel-Duby R. (1996) ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol. Cell. Biol. 16, 6644 6653.
39. Natesan S. Gilman M. Z. (1993) DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev. 7, 2497 2509.
40. Obeid R., Schadt A., Dillmann U., Kostopoulos P., Fassbender K. Herrmann W. (2009) Methylation status and neurodegenerative markers in Parkinson disease. Clin. Chem. 55, 1852 1860.
41. Perez-Buira S., Barrachina M., Rodriguez A., Albasanz J. L., Martín M. Ferrer I. (2007) Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease. Neurosci. Lett. 423, 194 199.
42. Peterfreund R. A., MacCollin M., Gusella J. Fink J. S. (1996) Characterization and expression of the human A2a adenosine receptor gene. J. Neurochem. 66, 362 368.
43. Pinna A. (2009) Novel investigational adenosine A2A receptor antagonists for Parkinson's disease. Expert Opin. Investig. Drugs 18, 1619 1631.
44. Popoli P., Pintor A., Domenici M. R. et al. (2002) Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22, 1967 1975.
45. Rodríguez A., Martín M., Albasanz J. L., Barrachina M., Espinosa J. C., Torres J. M. Ferrer I. (2006) Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice. J. Neuropathol. Exp. Neurol. 65, 964 975.
46. Rosin D. L., Robeva A., Woodard R. L., Guyenet P. G. Linden J. (1998) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J. Comp. Neurol. 401, 163 186.
47. Rylski M., Amborska R., Zybura K., Konopacki F. A., Wilczynski G. M. Kaczmarek L. (2008) Yin Yang 1 expression in the adult rodent brain. Neurochem. Res. 33, 2556 2564.
48. Scarpa S., Fuso A., D'Anselmi F. Cavallaro R. A. (2003) Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett. 541, 145 148.
49. Scarpa S., Cavallaro R. A., D'Anselmi F. Fuso A. (2006) Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J. Alzheimers Dis. 9, 407 414.
50. Schwarzschild M. A., Agnati L., Fuxe K., Chen J. F. Morelli M. (2006) Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29, 647 654.
51. Shi Y., Lee J. S. Galvin K. M. (1997) Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, F49 F66.
52. Shiotani A. Merchant J. L. (1995) cAMP regulates gastrin gene expression. Am. J. Physiol. 269, G458 G464.
53. Siegmund K. D., Connor C. M., Campan M., Long T. I., Weisenberger D. J., Biniszkiewicz D., Jaenisch R., Laird P. W. Akbarian S. (2007) DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2, e895.
54. Song F., Smith J. F., Kimura M. T., Morrow A. D., Matsuyama T., Nagase H. Held W. A. (2005) Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc. Natl Acad. Sci. USA 102, 3336 3341.
55. St. Hilaire C., Carroll S. H., Chen H. Ravid K. (2009) Mechanisms of induction of adenosine receptor genes and its functional significance. J. Cell. Physiol. 218, 35 44.
56. Stone T. W., Ceruti S. Abbracchio M. P. (2009) Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb. Exp. Pharmacol. 193, 535 587.
57. Thomas M. J. Seto E. (1999) Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236, 197 208.
58. Urdinguio R. G., Sanchez-Mut J. V. Esteller M. (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 8, 1056 1072.
59. Varani K., Vincenzi F., Tosi A. et al. (2010) A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. FASEB J. 24, 587 598.
60. Weber M., Hellmann I., Stadler M. B., Ramos L., Pääbo S., Rebhan M. Schübeler D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39, 457 466.
61. Wieczorek E., Lin Z., Perkins E. B., Law D. J., Merchant J. L. Zehner Z. E. (2000) The zinc finger repressor, ZBP-89, binds to the silencer element of the human vimentin gene and complexes with the transcriptional activator, Sp1. J. Biol. Chem. 275, 12879 12888.
62. Yamada A., Takaki S., Hayashi F., Georgopoulos K., Perlmutter R. M. Takatsu K. (2001) Identification and characterization of a transcriptional regulator for the lck proximal promoter. J. Biol. Chem. 276, 18082 18089.
63. Ye S., Whatling C., Watkins H. Henney A. (1999) Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89. FEBS Lett. 450, 268 272.
64. Yu L., Frith M. C., Suzuki Y. et al. (2004) Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res. 1000, 156 173.
65. Zhou Q., Gedrich R. W. Engel D. A. (1995) Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J. Virol. 69, 4323 4330.